Company: LBRX
Filing Date: 2025-09-12
Form Type: 8-K
Source: 0001193125-25-202195
Chunk: 1

Company: LB PHARMACEUTICALS INC
Filing Date: 2025-09-12
Form: 8-K
Item: Item 9.01
Chunk 1
---
Item 9.01      Financial Statements and Exhibits.  

(d) Exhibits.

  Exhibit      Description                                                                                                                                                                                           
                                                                                                                                                                                                                     
      No.                                                                                                                                                                                                            
 ─────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────
      3.1      Amended and Restated Certificate of Incorporation of the Registrant.                                                                                                                                  
      3.2      Amended and Restated Bylaws of the Registrant (incorporated herein by reference to Exhibit 3.4 to the Registrant’s Registration Statement on Form S-1 (File No. 333-289812), filed with the Commi...  
      104      Cover Page Interactive Data File (embedded within the Inline XBRL document).                                                                                                                          

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

  LB Pharmaceuticals Inc                               
  By:                         /s/ Heather Turner       
                              Heather Turner           
                              Chief Executive Officer  

Dated: September 12, 2025